Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumify in Glaucoma Patients Using Brimonidine
NCT04007276Phase 4Not yet recruiting
- Sponsor
- Tulane University
- Start
- Nov 2027
- Primary completion
- Nov 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine in ocular redness, sponsored by Tulane University. Planned start Nov 2027; status: not yet recruiting.
02
Drugs
brimonidine
03
Conditions
ocular redness
Beyond the preview
Go deeper on NCT04007276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04007276.